Publications by authors named "Marie-Christine Mathieu"

Claim this Profile
B
Breast tissue imaging atlas using ultra-fast confocal microscopy to identify cancer lesions.
Marie-Christine Mathieu, Moira Ragazzi, Malek Ferchiou, Paul J van Diest, Odile Casiraghi

Virchows Arch· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate Diagnosis of Breast Carcinoma on Core Needle Biopsy Using Ex Vivo Fluorescence Confocal Microscopy: Feasibility in a One-Stop Breast Clinic Workflow.
Marie-Christine Mathieu, Voichita Suciu, Marie-Laure Tanguy, Neila Ines Ben Romdhane, Salma Moalla

Life (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic.
Voichita Suciu, Carolla El Chamieh, Ranya Soufan, Marie-Christine Mathieu, Corinne Balleyguier

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Challenges and Pitfalls of Mammary Pleomorphic Adenoma Illustrated by a Case Report.
Natacha Joyon, Marie-Christine Mathieu, Etienne Rouleau, Aurélie Roulot-Paumelle, Jean-Yves Scoazec

Int J Surg Pathol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast carcinoma detection in ex vivo fresh human breast surgical specimens using a fast slide-free confocal microscopy scanner: HIBISCUSS project.
Angelica Conversano, Muriel Abbaci, Paul van Diest, Aurélie Roulot, Giuseppe Falco, Marie-Christine Mathieu

BJS Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automatic diagnosis and classification of breast surgical samples with dynamic full-field OCT and machine learning.
Jules Scholler, Diana Mandache, Marie Christine Mathieu, Aïcha Ben Lakhdar, Marie Darche

J Med Imaging (Bellingham)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary reverse mapping using near-infrared fluorescence imaging in invasive breast cancer (ARMONIC study).
Angelica Conversano, Muriel Abbaci, Maryam Karimi, Marie-Christine Mathieu, Frederic de Leeuw

Eur J Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-Infrared Fluorescence Axillary Reverse Mapping (ARM) Procedure in Invasive Breast Cancer: Relationship between Fluorescence Signal in ARM Lymph Nodes and Clinical Outcomes.
Muriel Abbaci, Angelica Conversano, Maryam Karimi, Marie-Christine Mathieu, Valérie Rouffiac

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France].
Camille Franchet, Lounes Djerroudi, Aurélie Maran-Gonzalez, Olivia Abramovici, Martine Antoine, Marie-Christine Mathieu

Ann Pathol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adipose Tissue Properties in Tumor-Bearing Breasts.
Isabelle Miran, Dominique Scherer, Pauline Ostyn, Chafika Mazouni, Françoise Drusch, Marie-Christine Mathieu

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Marie-Christine Mathieu

NPJ Breast Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting].
Aurélie Maran-Gonzalez, Camille Franchet, Raphaëlle Duprez-Paumier, Martine Antoine, Catherine Barlier, Marie-Christine Mathieu

Ann Pathol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS.
Corinne Balleyguier, Ariane Dunant, Luc Ceugnart, Marguerite Kandel, Marie-Pierre Chauvet, Marie-Christine Mathieu

J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer.
Mauro Loi, Ariane Dunant, Sahar Ghith, Almudena Maria Cascales-Garcia, Chafika Mazouni, Marie-Christine Mathieu

Cancer Invest· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations.
Yoan Ditchi, Chloé Broudin, Yolla El Dakdouki, Marie Muller, Pernelle Lavaud, Marie-Christine Mathieu

Breast J· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses.
Marie-Christine Mathieu, Alexis Toullec, Charlotte Benoit, Richard Berry, Pierre Validire

Eur Radiol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Carcinoma of unknown primary. Role of the pathologist in 2018: Introduction].
Janick Selves, Elodie Long-Mira, Marie-Christine Mathieu, Philippe Rochaix, Marius Ilié

Ann Pathol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Carcinoma of unknown primary. Case no. 8].
Marie-Christine Mathieu

Ann Pathol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.
Janick Selves, Elodie Long-Mira, Marie-Christine Mathieu, Philippe Rochaix, Marius Ilié

Cancers (Basel)· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily Biopsy Diagnosis in Surgical Pathology: Concordance Between Light Microscopy and Whole-Slide Imaging in Real-Life Conditions.
Irène Villa, Marie-Christine Mathieu, Jacques Bosq, Anne Auperin, Jean-François Pomerol

Am J Clin Pathol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Expression Is Predictive of Response to Neoadjuvant Celecoxib in -negative Breast Cancer Patients.
Patricia DE Cremoux, Anne-Sophie Hamy, Jacqueline Lehmann-Che, Véronique Scott, Brigitte Sigal, Marie-Christine Mathieu

Anticancer Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of whole breast magnetic resonance elastography added to MRI for lesion characterization.
Corinne Balleyguier, Aicha Ben Lakhdar, Ariane Dunant, Marie-Christine Mathieu, Suzette Delaloge

NMR Biomed· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Elsa Curtit, Xavier Pivot, Julie Henriques, Sophie Paget-Bailly, Pierre Fumoleau, Marie-Christine Mathieu

Breast Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status.
Sylvie Giacchetti, Anne-Sophie Hamy, Suzette Delaloge, Etienne Brain, Frédérique Berger, Marie-Christine Mathieu

Eur J Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
Xavier Pivot, Gilles Romieu, Pierre Fumoleau, Maria Rios, Hervé Bonnefoi, Marie-Christine Mathieu

NPJ Breast Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis